Another vaccine we really need in the US is getting closer to approval! Q: Will a serogroup B meningococcal vaccine eventually be licensed for use in the United States? A: It is possible that manufacturers will get this type of vaccine licensed in the United States in the future. In April 2011, an FDA advisory committee discussed the data available at that time about serogroup B meningococcal vaccines and approaches for getting those vaccines licensed in the United States. In spring 2014, Novartis and Pfizer both publicly acknowledged that they have received FDA Breakthrough Therapy designation for their serogroup B meningococcal vaccines. Novartis and Pfizer both issued press releases on June 17, 2014, announcing that they had submitted license applications for their serogroup B meningococcal vaccines to FDA. Questions regarding Novartis and Pfizers vaccines should be directed to the firms. Learn more from the FDA.
Posted on: Tue, 19 Aug 2014 03:37:19 +0000
Trending Topics
Recently Viewed Topics
© 2015